Breaking: US FDA Cancels Upcoming Adcomm Discussing 2025-2026 Flu Vaccine
The Vaccines and Related Biological Products Advisory Committee meeting next month was scheduled to select strains for the 2025-2026 flu vaccine. The cancellation could mean delays in vaccine availability.